Physician
Kamath, Shuba
Kamath, Shuba was paid $712K by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoKAMATH, SHUBA
PROVIDENCE, RI 02903
PROVIDENCE, RI 02903
33aNPI1295769941assigned 07/10/2006
33bProvider typePediatrics Physician
28Total paid$712K
24GClaims9,222
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#32 of 265
Median peer was paid$133K
This provider vs. median5.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,585 | $108K | |
| 2019 | 412 | $19K | |
| 2020 | 1,074 | $81K | |
| 2021 | 1,597 | $125K | |
| 2022 | 1,851 | $160K | |
| 2023 | 1,605 | $127K | |
| 2024incomplete | 1,098 | $92K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 3,198 | 3,033 | $280K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 15% | 1,815 | 1,746 | $110K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 671 | 560 | $81K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 417 | 405 | $53K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.8% | 274 | 261 | $35K |
| 90461 | 4.1% | 520 | 482 | $29K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.0% | 212 | 205 | $29K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 167 | 165 | $23K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.1% | 110 | 107 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 407 | 357 | $12K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 121 | 80 | $11K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.4% | 49 | 49 | $10K |
20 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 187 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 62 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 33 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 22 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 21 | $2K |
| 83655 | <1% | 85 | $2K | |
| 85027 | <1% | 96 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 45 | $1K |
| 99173 | <1% | 15 | $1K | |
| 96161 | <1% | 40 | $734.53 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 28 | $637.13 |
| 83718 | <1% | 31 | $636.07 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 55 | $597.74 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25 | $436.37 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 15 | $426.52 |
| 82465 | <1% | 31 | $338.37 | |
| 90686 | <1% | 428 | $214.00 | |
| 84460 | <1% | 13 | $170.40 | |
| 84450 | <1% | 13 | $166.17 | |
| 90656 | <1% | 16 | $8.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.